Search research articles
Contact Us
Filters
Showing results (181-190 of 256) with videos related to
Page
of 26
Sort By:
Molecular Medicine (Cambridge, Mass.)
|
May 29, 2012
HMGB1 mediates cognitive impairment in sepsis survivors
Sangeeta S Chavan, Patricio T Huerta, Sergio Robbiati, et al.
Annals of the Rheumatic Diseases
|
November 4, 2020
Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial
Cynthia Aranow, Yemil Atish-Fregoso, Martin Lesser, et al.
Journal of Autoimmunity
|
May 27, 2025
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus
Hugo J van Dooren, Yemil Atisha-Fregoso, Annemarie L Dorjée, et al.
Research Square
|
June 9, 2023
Lupus autoantibodies initiate a maladaptive equilibrium sustained by HMGB1:RAGE signaling and reversed by LAIR-1:C1q signaling
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Blood
|
September 30, 2016
C1q and HMGB1 reciprocally regulate human macrophage polarization
Myoungsun Son, Amit Porat, Mingzhu He, et al.
Rheumatology (Oxford, England)
|
December 14, 2024
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Hans-Joachim Anders, Tak Mao Chan, Jorge Sanchez-Guerrero, et al.
Molecular Medicine (Cambridge, Mass.)
|
December 9, 2022
Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever
Ibrahim T Mughrabi, Mahendar Ochani, Mirza Tanovic, et al.
Cell Research
|
April 21, 2010
Requirement for cyclin D3 in germinal center formation and function
Jonathan U Peled, J Jessica Yu, Jeganathan Venkatesh, et al.
Lupus Science & Medicine
|
August 16, 2019
Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
Elisabeth Ploran, Chris Tang, Meggan Mackay, et al.
BMJ Open
|
March 23, 2019
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
Y K Onno Teng, Ian N Bruce, Betty Diamond, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 256) with videos related to
Sort By:
Page
of 26
Molecular Medicine (Cambridge, Mass.)
|
May 29, 2012
HMGB1 mediates cognitive impairment in sepsis survivors
Sangeeta S Chavan, Patricio T Huerta, Sergio Robbiati, et al.
Annals of the Rheumatic Diseases
|
November 4, 2020
Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial
Cynthia Aranow, Yemil Atish-Fregoso, Martin Lesser, et al.
Journal of Autoimmunity
|
May 27, 2025
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus
Hugo J van Dooren, Yemil Atisha-Fregoso, Annemarie L Dorjée, et al.
Research Square
|
June 9, 2023
Lupus autoantibodies initiate a maladaptive equilibrium sustained by HMGB1:RAGE signaling and reversed by LAIR-1:C1q signaling
Kaitlin R Carroll, Mark Mizrachi, Sean Simmons, et al.
Blood
|
September 30, 2016
C1q and HMGB1 reciprocally regulate human macrophage polarization
Myoungsun Son, Amit Porat, Mingzhu He, et al.
Rheumatology (Oxford, England)
|
December 14, 2024
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Hans-Joachim Anders, Tak Mao Chan, Jorge Sanchez-Guerrero, et al.
Molecular Medicine (Cambridge, Mass.)
|
December 9, 2022
Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever
Ibrahim T Mughrabi, Mahendar Ochani, Mirza Tanovic, et al.
Cell Research
|
April 21, 2010
Requirement for cyclin D3 in germinal center formation and function
Jonathan U Peled, J Jessica Yu, Jeganathan Venkatesh, et al.
Lupus Science & Medicine
|
August 16, 2019
Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
Elisabeth Ploran, Chris Tang, Meggan Mackay, et al.
BMJ Open
|
March 23, 2019
Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
Y K Onno Teng, Ian N Bruce, Betty Diamond, et al.
Page
of 26